FDA's Bold Move Boosts Biosimilars, US-China Tensions Over Fentanyl, Artificial Cornea Innovation
Published on: March 11, 2026, 2:30 a.m. | Source: Devdiscourse
Today's health news spotlight includes the FDA's proposal to streamline biosimilar drug testing to reduce costs, heightened US-China disagreements over fentanyl at the UN, and noteworthy advancements by Spanish researchers in developing a cost-effective artificial cornea. These developments highlight ongoing global health challenges and innovations.
